This phenomenon is well documented in the cases of recurrent chemoresistant ovarian cancer which has been shown to reacquire DNA repair proficiency by reversion of BRCA1/BRCA2 mutations or modification of epigenetic marks [58,59]. Here, BRCA1 is linked to ovarian carcinoma.